UW Medicine | November 2, 2023
The Center for Behavioral Health and Learning promises to be a game-changer. It’s part of an ambitious new approach to caring for individuals living with serious mental illness.
Clinical Care & Consultation
Update: Center for Behavioral Health and Learning
Department news | September 28, 2023
The former “Behavioral Health Teaching Facility” is now the “Center for Behavioral Health and Learning.” This time, the letters for the building façade have been purchased so we suspect the new name will stick.
ADHD prescriptions skyrocket in Washington and nationwide
Axios | September 25, 2023
Greater recognition of how symptoms show up differently in women and girls is shifting who receives treatment for ADHD, which has historically been diagnosed more often in boys, says Douglas Russell, MD.
Misunderstanding chronic pain: a new look at opioids and pain relief
The Huddle | September 26, 2023
In their recently published book, The Right to Pain Relief and Other Deep Roots of the Opioid Epidemic, UW Medicine pain experts Mark Sullivan, MD, PhD, and Jane Ballantyne explore how doctors and patients have misused opioids and how they affect the brain.
New study of Asian, Native Hawaiian and Pacific Islander populations gets $38.7M grant
Fred Hutch News | September 14, 2023
Isaac Rhew, PhD, MPH, will provide expertise on mental health and acculturation for a new population study regarding the health of Asian American, Native Hawaiian and Pacific Islander populations in the U.S.
Specialized center helps youth amid suicidal crises
Children's Hospital Today | July 14, 2023
When emergency department visits for youth suicidality rose at Seattle Children’s from about 2,000 in 2015 to nearly 3,500 in just three years, it became clear they needed a new approach. Molly Adrian, PhD, is quoted.
More adults than ever have been seeking ADHD medications – an ADHD expert explains what could be driving the trend
The Conversation | August 4, 2023
In March 2023, the U.S. Centers for Disease Control and Prevention reported an unprecedented spike in stimulant prescriptions between 2020 and 2021. Margaret Sibley, PhD, offers her perspective.
Podcast: The untapped potential of psychedelics in psychotherapy
Crosscut | July 27, 2023
Research shows psychedelic drugs such as psilocybin and ketamine can be effective in treating depression, post-traumatic stress and substance-use disorders — but there’s still much we don’t know. Nathan Sackett, MD, MS, acting assistant professor of psychiatry and behavioral sciences in the UW School of Medicine, is interviewed.
Washington doctors detail pros, cons of fentanyl addiction treatment methods
The Seattle Times | July 24, 2023
"A lot of the things that we took as fact were not accurate," says Mark Duncan, MD, of macrodosing Buprenorphine, an alternative method for treating fentanyl overdose.
Seattle’s Top Docs 2023
Seattle magazine | July 5, 2023
Congratulations to Jesse Fann, MD, MPH, Ray Hsiao, MD, Ian Kodish, MD, PhD, Hower Kwon, MD, Kathleen Myers, MD, Richard Ries, MD, FAPA, FASM, Carol Rockhill, MD, PhD, MPH, Peter Roy-Byrne, MD, Andrew Saxon, MD, Gregory Simon, MD, MPH, and Mark Snowden, MD, MPH, for being named a 2023 Top Doc!
